Saibia Third generation capillary heme detection reagent - Taiwan Registration d19ab70e316738317a9047b2dc4d8c39
Access comprehensive regulatory information for Saibia Third generation capillary heme detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d19ab70e316738317a9047b2dc4d8c39 and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including SEBIA, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses capillary electrophoresis to isolate normal heme (A, F and A2) in an alkaline buffer (pH 9.4) and detect the main variants of heme (S, C, E, and D). SUITABLE FOR SEBIA CAPILLARYS 3 INSTRUMENTS.
B Hematology, pathology, and genetics
B.7440 Heme electrophoresis analysis system
import
Dates and Status
Oct 17, 2019
Oct 17, 2029